Fortress Biotech
FBIO
#9223
Rank
โ‚ฌ87.89 M
Marketcap
2,83ย โ‚ฌ
Share price
-3.21%
Change (1 day)
63.31%
Change (1 year)

Operating Margin for Fortress Biotech (FBIO)

Operating Margin as of December 2025 (TTM): -85.82%

According to Fortress Biotech 's latest financial reports and stock price the company's current Operating Margin is -85.82%. At the end of 2024 the company had an Operating Margin of -209.00%.

Operating Margin history for Fortress Biotech from 2016 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-209.00%14.97%
2023-181.79%-35.5%
2022-281.83%17.96%
2021-238.92%5.93%
2020-225.55%-18.73%
2019-277.54%-42.96%
2018-486.57%-13.95%
2017-565.46%30.72%
2016-432.58%-93.07%
2015-6,243.68%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Advaxis
ADXS
-399,877.00% 465,848.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
4.99%-105.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%-28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
11.12%-112.96%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.